Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Steven Mah is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/26/2024 | TWST | Buy Now | Twist Bioscience | $41.73 | 38.99% | Steven Mah52% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | BLFS | Buy Now | BioLife Solns | $25.48 | 21.66% | Steven Mah52% | $28 → $31 | Maintains | Buy | Get Alert |
| 07/17/2024 | BLFS | Buy Now | BioLife Solns | $25.48 | 2.04% | Steven Mah52% | $20 → $26 | Maintains | Buy | Get Alert |
| 06/13/2024 | TWST | Buy Now | Twist Bioscience | $41.73 | 55.76% | Steven Mah52% | $55 → $65 | Maintains | Buy | Get Alert |
| 03/01/2024 | DNA | Buy Now | Ginkgo Bioworks Holdings | $7.73 | -61.19% | Steven Mah52% | $280 → $120 | Maintains | Outperform | Get Alert |
| 01/26/2024 | RXRX | Buy Now | Recursion Pharmaceuticals | $6.70 | — | Steven Mah52% | — | Initiates | → Market Perform | Get Alert |
| 01/26/2024 | SDGR | Buy Now | Schrodinger | $22.51 | 86.58% | Steven Mah52% | → $42 | Initiates | → Outperform | Get Alert |
| 08/23/2023 | CELL | Buy Now | PhenomeX | — | — | Steven Mah52% | → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/28/2023 | ABCL | Buy Now | AbCellera Biologics | $2.41 | — | Steven Mah52% | — | Initiates | → Outperform | Get Alert |
| 02/22/2023 | OABI | Buy Now | OmniAb | $2.66 | 275.94% | Steven Mah52% | → $10 | Initiates | → Outperform | Get Alert |
| 09/22/2022 | ME | Buy Now | 23andMe Holding | $1.87 | 220.86% | Steven Mah52% | → $120 | Initiates | → Outperform | Get Alert |
| 08/12/2022 | ABSI | Buy Now | Absci | $2.96 | — | Steven Mah52% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 07/15/2022 | CDXS | Buy Now | Codexis | $2.66 | 689.47% | Steven Mah52% | $39 → $21 | Maintains | Outperform | Get Alert |
| 03/02/2022 | DNA | Buy Now | Ginkgo Bioworks Holdings | $7.73 | 55.24% | Steven Mah52% | → $480 | Initiates | → Outperform | Get Alert |
| 08/12/2021 | TLIS | Buy Now | Talis Biomedical | $1.61 | 459.01% | Steven Mah52% | → $135 | Downgrade | Overweight → Neutral | Get Alert |
| 08/04/2021 | HSKA | Buy Now | Heska | — | — | Steven Mah52% | $240 → $305 | Maintains | Overweight | Get Alert |
| 07/06/2021 | NTRA | Buy Now | Natera | $150.87 | 2.74% | Steven Mah52% | $150 → $155 | Maintains | Overweight | Get Alert |
| 05/11/2021 | AKYA | Buy Now | Akoya Biosciences | $1.68 | 1566.67% | Steven Mah52% | → $28 | Initiates | → Overweight | Get Alert |
| 04/13/2021 | LMNX | Buy Now | Luminex | — | — | Steven Mah52% | $38 → $37 | Downgrade | Overweight → Neutral | Get Alert |
| 04/12/2021 | TWST | Buy Now | Twist Bioscience | $41.73 | 259.45% | Steven Mah52% | → $150 | Initiates | → Overweight | Get Alert |
| 04/12/2021 | CDXS | Buy Now | Codexis | $2.66 | 1103.01% | Steven Mah52% | → $32 | Initiates | → Overweight | Get Alert |
| 03/09/2021 | TLIS | Buy Now | Talis Biomedical | $1.61 | 955.9% | Steven Mah52% | → $255 | Initiates | → Overweight | Get Alert |
| 03/05/2021 | FLGT | Buy Now | Fulgent Genetics | $16.87 | 729.88% | Steven Mah52% | $135 → $140 | Maintains | Overweight | Get Alert |
| 02/26/2021 | NTRA | Buy Now | Natera | $150.87 | -0.58% | Steven Mah52% | $127 → $150 | Maintains | Overweight | Get Alert |
| 02/24/2021 | HSKA | Buy Now | Heska | — | — | Steven Mah52% | $157 → $220 | Maintains | Overweight | Get Alert |
| 02/22/2021 | OCDX | Buy Now | Ortho Clinical Diagnostic | — | — | Steven Mah52% | → $27 | Initiates | → Overweight | Get Alert |
| 02/11/2021 | PACB | Buy Now | Pacific Biosciences | $1.26 | 4026.98% | Steven Mah52% | $20 → $52 | Upgrade | Neutral → Overweight | Get Alert |
| 01/07/2021 | OXFD | Buy Now | Oxford Immunotec Global | — | — | Steven Mah52% | $24 → $22 | Downgrade | Overweight → Neutral | Get Alert |
| 12/22/2020 | ILMN | Buy Now | Illumina | $87.00 | 377.01% | Steven Mah52% | $340 → $415 | Upgrade | Neutral → Overweight | Get Alert |
| 12/16/2020 | OCX | Buy Now | OncoCyte | $3.33 | 20.12% | Steven Mah52% | $40 → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 11/03/2020 | PACB | Buy Now | Pacific Biosciences | $1.26 | — | Steven Mah52% | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/01/2020 | PACB | Buy Now | Pacific Biosciences | $1.26 | 852.38% | Steven Mah52% | $6 → $12 | Maintains | Overweight | Get Alert |
| 08/07/2020 | ILMN | Buy Now | Illumina | $87.00 | 290.8% | Steven Mah52% | $356 → $340 | Downgrade | Overweight → Neutral | Get Alert |
| 07/27/2020 | FLGT | Buy Now | Fulgent Genetics | $16.87 | 83.76% | Steven Mah52% | $21 → $31 | Maintains | Overweight | Get Alert |
| 07/08/2020 | QDEL | Buy Now | QuidelOrtho | $34.78 | 618.8% | Steven Mah52% | $168 → $250 | Maintains | Overweight | Get Alert |
| 06/17/2020 | FLGT | Buy Now | Fulgent Genetics | $16.87 | 24.48% | Steven Mah52% | $18 → $21 | Maintains | Overweight | Get Alert |
| 05/14/2020 | NTRA | Buy Now | Natera | $150.87 | -62.88% | Steven Mah52% | $49 → $56 | Maintains | Overweight | Get Alert |
| 02/27/2020 | NTRA | Buy Now | Natera | $150.87 | -67.52% | Steven Mah52% | $45 → $49 | Reiterates | → Overweight | Get Alert |
| 01/09/2020 | ILMN | Buy Now | Illumina | $87.00 | 325.29% | Steven Mah52% | $341 → $370 | Maintains | Overweight | Get Alert |
| 10/25/2019 | ILMN | Buy Now | Illumina | $87.00 | 291.95% | Steven Mah52% | $348 → $341 | Maintains | Overweight | Get Alert |
| 11/03/2015 | LMNX | Buy Now | Luminex | — | — | Steven Mah52% | $17 → $19 | Maintains | Neutral | Get Alert |
| 07/09/2012 | LMNX | Buy Now | Luminex | — | — | Steven Mah52% | $21 → $18 | Maintains | Underweight | Get Alert |
| 05/01/2012 | LMNX | Buy Now | Luminex | — | — | Steven Mah52% | $19 → $21 | Maintains | Underweight | Get Alert |
